Jefferies Downgrades Icon PLC (ICLR.US) to "Hold" Due to Excessive Headwinds

Stock News

Sep 15

Jefferies analyst David Windley has downgraded Icon PLC (ICLR.US) from "Buy" to "Hold" and reduced the target price from $220 to $175. Windley now believes Icon PLC faces "too many" unfavorable factors, leading to the withdrawal of his recommendation for the stock. Despite the shares appearing "cheap," he anticipates potential further downward revisions to performance expectations.

Jefferies noted that ongoing channel surveys continue to show Icon PLC losing wallet share, which undermines the growth momentum generated from winning four partnership agreements since the PRA Health merger. The firm also indicated that third-quarter customer cancellations could approach $1 billion, with this figure likely remaining elevated in the fourth quarter.

Icon PLC is a clinical research organization that provides outsourced research and development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in managing, developing, and analyzing clinical development-related projects. Its operations span across Ireland, other parts of Europe, and the United States.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1141664441"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1141664441\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1141664441?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-15 14:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141664441","market":"fut","top_or_hot":-1,"title":"Jefferies Downgrades Icon PLC (ICLR.US) to \"Hold\" Due to Excessive Headwinds","media":"Stock News","content":"<p>Jefferies analyst David Windley has downgraded Icon PLC (ICLR.US) from \"Buy\" to \"Hold\" and reduced the target price from $220 to $175. Windley now believes Icon PLC faces \"too many\" unfavorable factors, leading to the withdrawal of his recommendation for the stock. Despite the shares appearing \"cheap,\" he anticipates potential further downward revisions to performance expectations.</p>\n<p>Jefferies noted that ongoing channel surveys continue to show Icon PLC losing wallet share, which undermines the growth momentum generated from winning four partnership agreements since the PRA Health merger. The firm also indicated that third-quarter customer cancellations could approach $1 billion, with this figure likely remaining elevated in the fourth quarter.</p>\n<p>Icon PLC is a clinical research organization that provides outsourced research and development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in managing, developing, and analyzing clinical development-related projects. Its operations span across Ireland, other parts of Europe, and the United States.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jefferies Downgrades Icon PLC (ICLR.US) to \"Hold\" Due to Excessive Headwinds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJefferies Downgrades Icon PLC (ICLR.US) to \"Hold\" Due to Excessive Headwinds\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-09-15 14:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jefferies analyst David Windley has downgraded Icon PLC (ICLR.US) from \"Buy\" to \"Hold\" and reduced the target price from $220 to $175. Windley now believes Icon PLC faces \"too many\" unfavorable factors, leading to the withdrawal of his recommendation for the stock. Despite the shares appearing \"cheap,\" he anticipates potential further downward revisions to performance expectations.</p>\n<p>Jefferies noted that ongoing channel surveys continue to show Icon PLC losing wallet share, which undermines the growth momentum generated from winning four partnership agreements since the PRA Health merger. The firm also indicated that third-quarter customer cancellations could approach $1 billion, with this figure likely remaining elevated in the fourth quarter.</p>\n<p>Icon PLC is a clinical research organization that provides outsourced research and development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in managing, developing, and analyzing clinical development-related projects. Its operations span across Ireland, other parts of Europe, and the United States.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0289739343.SGD","symbol_name":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","start_time":0,"source_url":"","article_id":"1141664441","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141664441","pubTimestamp":1757916625,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Jefferies analyst David Windley has downgraded Icon PLC (ICLR.US) from \"Buy\" to \"Hold\" and reduced the target price from $220 to $175. Windley now believes Icon PLC faces \"too many\" unfavorable...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","LU0029864427.USD":"TEMPLETON GLOBAL \"A\" (USD) INC","LU0882574055.USD":"富达全球健康医疗A ACC","LU0511384066.AUD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (AUDHDG) ACC","LU1043141396.HKD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (HKD) ACC","BK4532":"文艺复兴科技持仓","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","BK4121":"生命科学工具和服务","LU0289960550.SGD":"AB FCP I - GLOBAL EQUITY BLEND PORTFOLIO 'A' (SGD) ACC","LU0728928796.USD":"abrdn SICAV I - GLOBAL SMALL&MID-CAP SDG HORIZONS EQUITY \"A\" (USD) ACC","LU0128525929.USD":"TEMPLETON GLOBAL \"A\" (USD) ACC","LU0187121727.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) INC","LU1043141123.HKD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (HKD) INC 2","LU0792757196.USD":"TEMPLETON SHARIAH GLOBAL EQUITY FUND \"A\" (USD) ACC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","ICLR":"ICON plc","LU1983260115.SGD":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","LU2244417387.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) ACC","LU0175139822.USD":"AB FCP I Global Equity Blend A USD","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","LU0994945656.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) INC 2","LU0310800379.SGD":"FTIF - Templeton Global A Acc SGD","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU1267930573.SGD":"TEMPLETON GLOBAL \"AA\" (SGD) ACC A","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU0528227936.USD":"富达环球人口趋势基金A-ACC","LU0889566641.SGD":"FTSF - Templeton Shariah Global Equity A Acc SGD","LU1691799644.USD":"Amundi Funds Polen Capital Global Growth A2 (C) USD","LU1121112475.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USDHDG) ACC","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU0289961442.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (SGD) ACC","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","LU1267930813.SGD":"FRANKLIN TEMPLETON SHARIAH GLOBAL EQUITY \"AS\" (SGD) ACC","LU0708994859.HKD":"TEMPLETON GLOBAL \"A\" (HKD) ACC","LU0426412945.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) ACC","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","LU0472753341.HKD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (HKD) ACC","LU0069063385.USD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (USD) ACC","LU0057025933.USD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (USD) ACC","LU0426417589.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) INC"},"translate_title":"由于阻力过大，杰富瑞将Icon PLC(ICLR.US)评级下调至“持有”","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ICLR":1},"content_text":"Jefferies analyst David Windley has downgraded Icon PLC (ICLR.US) from \"Buy\" to \"Hold\" and reduced the target price from $220 to $175. Windley now believes Icon PLC faces \"too many\" unfavorable factors, leading to the withdrawal of his recommendation for the stock. Despite the shares appearing \"cheap,\" he anticipates potential further downward revisions to performance expectations.\nJefferies noted that ongoing channel surveys continue to show Icon PLC losing wallet share, which undermines the growth momentum generated from winning four partnership agreements since the PRA Health merger. The firm also indicated that third-quarter customer cancellations could approach $1 billion, with this figure likely remaining elevated in the fourth quarter.\nIcon PLC is a clinical research organization that provides outsourced research and development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in managing, developing, and analyzing clinical development-related projects. Its operations span across Ireland, other parts of Europe, and the United States.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}